|
US20020106412A1
(en)
*
|
2000-07-10 |
2002-08-08 |
Therics, Inc |
Method and materials for controlling migration of binder liquid in a powder
|
|
WO1998036738A1
(en)
|
1997-02-20 |
1998-08-27 |
Therics, Inc. |
Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
|
|
KR100554924B1
(ko)
|
1998-05-18 |
2006-03-03 |
다케다 야쿠힌 고교 가부시키가이샤 |
구강내 붕괴 정제
|
|
US6284270B1
(en)
*
|
1999-08-04 |
2001-09-04 |
Drugtech Corporation |
Means for creating a mass having structural integrity
|
|
IL159287A0
(en)
*
|
2001-06-28 |
2004-06-01 |
Ucb Farchim Sa |
Tablet comprising cetirizine and pseudoephedrine
|
|
AU2002320360B2
(en)
*
|
2001-07-10 |
2005-05-26 |
Teva Pharmaceutical Industries Ltd. |
Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
|
|
US20030099708A1
(en)
*
|
2001-10-29 |
2003-05-29 |
Therics, Inc |
Printing or dispensing a suspension such as three-dimensional printing of dosage forms
|
|
CA2464478C
(en)
*
|
2001-10-29 |
2012-03-20 |
Therics, Inc. |
A system and method for uniaxial compression of an article, such as a three-dimensionally printed dosage form
|
|
AU2003232078A1
(en)
|
2002-05-06 |
2003-11-17 |
Massachusetts Institute Of Technology |
Diffusion-controlled dosage form and method of fabrication including three dimensional printing
|
|
WO2004047793A1
(en)
|
2002-11-26 |
2004-06-10 |
Alk-Abelló A/S |
Pharmaceutical allergen product
|
|
DK1804804T3
(da)
|
2004-09-21 |
2012-02-20 |
Hypnion Inc |
3-[4-(dibenzo[b,f][1,4]oxazepin-11-yl)-piperazin-1-yl]-2,2-dimethylpropansyre til anvendelse ved behandlingen af søvnforstyrrelser
|
|
US7829000B2
(en)
*
|
2005-02-25 |
2010-11-09 |
Hewlett-Packard Development Company, L.P. |
Core-shell solid freeform fabrication
|
|
US8187659B2
(en)
|
2006-05-02 |
2012-05-29 |
Jerry Robertson Real Estate Llc |
Solid medicament dosage form consumption aid
|
|
ES2500165T3
(es)
|
2006-06-29 |
2014-09-30 |
Kinex Pharmaceuticals, Llc |
Composiciones de biarilo y métodos para modular una cascada de quinasas
|
|
EP3777832A1
(en)
|
2007-10-20 |
2021-02-17 |
Athenex, Inc. |
Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof
|
|
TR201902233T4
(tr)
|
2009-10-30 |
2019-03-21 |
Ix Biopharma Ltd |
Hızlı çözünen katı dozaj formu.
|
|
US12186426B2
(en)
|
2009-10-30 |
2025-01-07 |
Ix Biopharma Ltd. |
Solid dosage form
|
|
WO2011123180A1
(en)
*
|
2010-04-03 |
2011-10-06 |
Praful Doshi |
Medical devices including medicaments and methods of making and using same
|
|
WO2012056319A1
(en)
|
2010-10-27 |
2012-05-03 |
Dynamix Pharmaceuticals Ltd. |
Sulfonamides for the modulation of pkm2
|
|
EP2655334B1
(en)
|
2010-12-22 |
2018-10-03 |
Eutropics Pharmaceuticals, Inc. |
Compositions and methods useful for treating diseases
|
|
US8722636B2
(en)
|
2011-01-31 |
2014-05-13 |
New Market Pharmaceuticals, LLC |
Animal treatments
|
|
WO2012122370A2
(en)
|
2011-03-08 |
2012-09-13 |
Eutropics Pharmaceuticals, Inc. |
Compositions and methods useful for treating diseases
|
|
ITMI20110792A1
(it)
|
2011-05-09 |
2012-11-10 |
Probiotical Spa |
Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
|
|
ITMI20110791A1
(it)
|
2011-05-09 |
2012-11-10 |
Probiotical Spa |
Ceppi di batteri in grado di metabolizzare gli ossalati.
|
|
ITMI20110793A1
(it)
|
2011-05-09 |
2012-11-10 |
Probiotical Spa |
Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
|
|
WO2012160447A1
(en)
|
2011-05-25 |
2012-11-29 |
Dynamix Pharmaceuticals Ltd. |
3, 5 -diphenyl- substituted pyrazolines for the treatment of cancer, proliferative, inflammatory or autoimmune diseases
|
|
PT2718290T
(pt)
|
2011-06-07 |
2016-07-14 |
Clevexel Pharma |
Composições e métodos para modular uma quinase
|
|
ITMI20111718A1
(it)
|
2011-09-23 |
2013-03-24 |
Probiotical Spa |
Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
|
|
US9245061B2
(en)
*
|
2012-04-25 |
2016-01-26 |
Shapeways, Inc. |
Weight-based identification of three dimensional printed parts
|
|
BR112014027352B1
(pt)
|
2012-05-02 |
2022-10-25 |
New Market Pharmaceuticals |
Composições farmacêuticas para a introdução sistêmica direta
|
|
IN2014DN11205A
(OSRAM)
|
2012-06-20 |
2015-10-02 |
Eutropics Pharmaceuticals Inc |
|
|
JP6499076B2
(ja)
|
2012-08-30 |
2019-04-10 |
アセネックス インコーポレイテッド |
タンパク質チロシンキナーゼ調節因子としてのｎ−（３−フルオロベンジル）−２−（５−（４−モルホリノフェニル）ピリジン−２−イル）アセトアミド
|
|
WO2014116770A1
(en)
|
2013-01-23 |
2014-07-31 |
Arx, Llc |
Production of unit dose constructs
|
|
CA2906107C
(en)
*
|
2013-03-15 |
2021-08-24 |
Aprecia Pharmaceuticals Company |
Rapidly dispersible dosage form of oxcarbazepine
|
|
WO2014144661A1
(en)
|
2013-03-15 |
2014-09-18 |
Aprecia Pharmaceuticals Compny |
Rapidly dispersible dosage form of topiramate
|
|
US9339489B2
(en)
|
2013-03-15 |
2016-05-17 |
Aprecia Pharmaceuticals Company |
Rapid disperse dosage form containing levetiracetam
|
|
AU2014228990B2
(en)
|
2013-03-15 |
2017-02-02 |
Aprecia Pharmaceuticals LLC |
Rapid disperse dosage form containing levetiracetam
|
|
US10994013B2
(en)
|
2013-04-24 |
2021-05-04 |
Temple University—Of the Commonwealth System of Higher Education |
Solid dosage form containing arabinogalactan
|
|
ITMI20130793A1
(it)
|
2013-05-14 |
2014-11-15 |
Probiotical Spa |
Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
|
|
KR102171123B1
(ko)
|
2013-08-16 |
2020-10-29 |
더 엑스원 컴퍼니 |
３차원 인쇄된 금속 주조용 몰드 및 그를 제조하기 위한 방법
|
|
JP2016540887A
(ja)
|
2013-10-17 |
2016-12-28 |
ザ エクスワン カンパニー |
３次元印刷された熱間静水圧加圧成形用容器及びその製造方法
|
|
EP3086920B1
(en)
|
2013-12-23 |
2019-07-24 |
The Exone Company |
Methods and systems for three-dimensional printing utilizing multiple binder fluids
|
|
WO2015100084A1
(en)
|
2013-12-23 |
2015-07-02 |
The Exone Company |
Method of three-dimensional printing using a multi-component build powder
|
|
US20160325495A1
(en)
*
|
2013-12-23 |
2016-11-10 |
The Exone Company |
Methods and Systems for Three-Dimensional Printing Utilizing a Jetted-Particle Binder Fluid
|
|
CN106255511A
(zh)
*
|
2014-04-30 |
2016-12-21 |
A·H·布莱斯 |
熔融加工聚合物细胞状剂型
|
|
WO2015183796A1
(en)
|
2014-05-29 |
2015-12-03 |
The Exone Company |
Process for making nickel-based superalloy articles by three-dimensional printing
|
|
US20170203514A1
(en)
|
2014-07-17 |
2017-07-20 |
The Exone Company |
Methods and Apparatuses for Curing Three-Dimensional Printed Articles
|
|
HUE046869T2
(hu)
|
2014-11-21 |
2020-04-28 |
Biohaven Therapeutics Ltd |
Riluzol szublingvális formulációja
|
|
ES2832588T3
(es)
|
2014-12-03 |
2021-06-10 |
The Exone Co |
Proceso para fabricar artículos de carbono densificados mediante impresión tridimensional
|
|
EP4512394A3
(en)
|
2015-06-03 |
2025-10-22 |
Triastek, Inc. |
Dosage forms and use thereof
|
|
EP3108874A1
(en)
*
|
2015-06-26 |
2016-12-28 |
TRB Chemedica AG |
Ophthalmologic pharmaceutical composition
|
|
US11129798B2
(en)
*
|
2016-08-19 |
2021-09-28 |
Aron H. Blaesi |
Fibrous dosage form
|
|
EP3368010B1
(en)
*
|
2015-10-26 |
2025-12-10 |
Blaesi, Aron H. |
Solid dosage form immediate drug release and apparatus and method for manufacture thereof
|
|
JP2019508449A
(ja)
*
|
2016-03-18 |
2019-03-28 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
種々の効能を有する薬物の組み合わせ
|
|
ITUA20162013A1
(it)
|
2016-03-24 |
2017-09-24 |
Probiotical Spa |
Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica.
|
|
EP3441065B1
(en)
*
|
2016-04-06 |
2024-10-09 |
Astellas Pharma Inc. |
Fast-eluting three-dimensional molding, filament for fast-eluting three-dimensional molding, and material for fast-eluting three-dimensional molding
|
|
CN107847398B
(zh)
|
2016-05-05 |
2019-05-07 |
南京三迭纪医药科技有限公司 |
控制释放的药物剂型
|
|
IL292302B2
(en)
|
2016-05-20 |
2023-10-01 |
Biohaven Pharm Holding Co Ltd |
Use of glutamate modulating factors in cancer immunotherapy
|
|
EP3497099B1
(en)
|
2016-08-12 |
2022-03-02 |
Athenex, Inc. |
Biaryl compositions and methods for modulating a kinase cascade
|
|
WO2018075628A1
(en)
|
2016-10-19 |
2018-04-26 |
Shapeways, Inc. |
Systems and methods for identifying three-dimensional printed objects
|
|
SG10202107367SA
(en)
|
2016-12-31 |
2021-08-30 |
Bioxcel Therapeutics Inc |
Use of sublingual dexmedetomidine for the treatment of agitation
|
|
CA3051614A1
(en)
|
2017-01-26 |
2018-08-02 |
Triastek, Inc. |
Dosage forms of controlled release at specific gastrointestinal sites
|
|
US11602502B2
(en)
|
2017-02-24 |
2023-03-14 |
Hewlett-Packard Development Company, L.P. |
Three-dimensional (3D) printing a pharmaceutical tablet
|
|
DK3592337T3
(da)
|
2017-03-08 |
2023-09-18 |
Cinrx Pharma Llc |
Farmaceutiske formuleringer af phloroglucinol og trimethylphloroglucinol
|
|
EP3635045A1
(en)
|
2017-05-26 |
2020-04-15 |
Infinite Material Solutions, LLC |
Water soluble polymer compositions
|
|
MD3706739T2
(ro)
|
2017-11-12 |
2025-02-28 |
Biohaven Therapeutics Ltd |
Utilizarea promedicamentelor de riluzol pentru tratarea ataxiei
|
|
CN108066302B
(zh)
*
|
2017-12-28 |
2020-09-11 |
无限极（中国）有限公司 |
一种快速分散固体制剂的制备方法及制备的快速分散固体制剂
|
|
US11571391B2
(en)
|
2018-01-09 |
2023-02-07 |
Triastek, Inc. |
Oral drug dosage forms compromising a fixed-dose of an ADHD non-stimulant and an ADHD stimulant
|
|
US10350822B1
(en)
|
2018-01-09 |
2019-07-16 |
Triastek Inc. |
Dosage forms with desired release profiles and methods of designing and making thereof
|
|
DE102018107585B3
(de)
*
|
2018-03-29 |
2019-03-28 |
Universität Rostock |
Vorrichtung zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen mit Wirkstoffdepots, sowie Verfahren zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen
|
|
ES3004544T3
(en)
|
2018-06-27 |
2025-03-12 |
Bioxcel Therapeutics Inc |
Film formulations containing dexmedetomidine and methods of producing them
|
|
EP3866757B1
(en)
|
2018-10-15 |
2022-08-10 |
Aprecia Pharmaceuticals LLC |
Method and system for forming a dosage form within a packaging
|
|
WO2020104837A1
(en)
|
2018-11-21 |
2020-05-28 |
Rosemont Pharmaceuticals Limited |
Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability
|
|
US12103229B2
(en)
*
|
2019-03-15 |
2024-10-01 |
Ricoh Company, Ltd. |
Jettable temporary binders to create removable support materials
|
|
JP7287032B2
(ja)
|
2019-03-20 |
2023-06-06 |
株式会社リコー |
シート、シート積層体、医薬品、シートの製造方法、及びシート積層体の製造方法
|
|
JP2022533213A
(ja)
*
|
2019-05-21 |
2022-07-21 |
ディーエフイー ファーマ ゲーエムベーハー ウント コー カーゲー |
ラクトース粉末床３次元印刷
|
|
US20240024288A1
(en)
|
2019-07-19 |
2024-01-25 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|
|
EP3789015A1
(en)
*
|
2019-09-05 |
2021-03-10 |
Universität Innsbruck |
Fast consolidating compounds
|
|
TWI734309B
(zh)
*
|
2019-12-19 |
2021-07-21 |
水星生醫股份有限公司 |
滲透性噴塗製作藥錠裝置
|
|
US12371581B2
(en)
|
2020-03-25 |
2025-07-29 |
Infinite Material Solutions, Llc |
High performance water soluble polymer compositions
|
|
AU2021296908A1
(en)
|
2020-06-26 |
2023-02-16 |
Aprecia Pharmaceuticals LLC |
Rapidly-orodispersible tablets having an interior cavity
|
|
WO2022089588A1
(zh)
|
2020-10-30 |
2022-05-05 |
南京三迭纪医药科技有限公司 |
胃滞留药物剂型
|
|
WO2022155564A1
(en)
|
2021-01-18 |
2022-07-21 |
Biohaven Therapeutics Ltd. |
Use of riluzole prodrugs to treat alzheimer's disease
|
|
WO2024108082A1
(en)
|
2022-11-18 |
2024-05-23 |
Aprecia Pharmaceuticals LLC |
Orodispersive dosage forms containing droxidopa
|
|
US11806334B1
(en)
|
2023-01-12 |
2023-11-07 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|